MEDICURE INC. Files October 2024 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Nov 18, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
MEDICURE INC. filed its monthly 6-K, just a routine update, no big news.
AI Summary
On October 24, 2024, MEDICURE INC. filed a Form 6-K with the SEC, reporting its activities for the month of October 2024. The company, based in Winnipeg, Canada, is a foreign private issuer and will file its annual reports under Form 20-F. This filing does not appear to contain specific financial figures or material events beyond the routine reporting.
Why It Matters
This filing serves as a routine update for investors, indicating the company's ongoing compliance and reporting status as a foreign private issuer.
Risk Assessment
Risk Level: low — The filing is a standard Form 6-K, indicating routine reporting rather than a material event or significant financial disclosure.
Key Players & Entities
- MEDICURE INC. (company) — Registrant
- October 24, 2024 (date) — Report Date
- Winnipeg, Canada (location) — Company Headquarters
- Form 20-F (document) — Annual Report Filing
- Form 6-K (document) — Report Type
FAQ
What is the primary purpose of this Form 6-K filing by MEDICURE INC.?
The primary purpose is to report on the company's activities for the month of October 2024 as a foreign private issuer.
Where is MEDICURE INC. headquartered?
MEDICURE INC. is headquartered at 2-1250 Waverley Street, Winnipeg, MB, Canada.
Which form does MEDICURE INC. use for its annual reports?
MEDICURE INC. files its annual reports under cover of Form 20-F.
What is the SEC file number for MEDICURE INC.?
The SEC file number for MEDICURE INC. is 001-31995.
Does this filing indicate any specific financial results or material events?
No, this filing is a routine Form 6-K and does not appear to contain specific financial results or details of material events beyond the reporting requirement.
Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-11-18 17:00:27
Filing Documents
- med_6k.htm (6-K) — 11KB
- med_ex991.htm (EX-99.1) — 13KB
- med_ex991img2.jpg (GRAPHIC) — 3KB
- 0001654954-24-014615.txt ( ) — 29KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: October 24, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3